According to the Centers for Disease Control and Prevention, an estimated 40 million American adults currently smoke, and smoking is the leading cause of preventable disease and death across the nation. A new smart trans-dermal patch could provide advantages over existing smoking cessation tools such as current nicotine patches, e-cigarettes and nicotine gum. Prospectively, the device will deliver high doses of nicotine before the user wakes, and before lunch and dinner mealtimes. A smartphone app is used to program the device dosing times and also provides motivational and behavioral support. Varying the amount of nicotine administered throughout the day may reduce cravings and could improve cigarette withdrawal and cessation outcome. Additional clinical trials are required to determine the effectiveness of this treatment.
The device is still not approved by the FDA. Once approved, Chrono expects the cost to the consumer will be between $400 and $500 for a 10-week course of therapy. you can learn more about this device from Chrono Therapeutics.